39
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Neutralising Antibodies to the Granulocyte Colony-stimulating Factor Receptor Recognise both the Immunoglobulin-like Domain and the Cytokine Receptor Homologous Domain

, &
Pages 117-130 | Received 23 Jul 1996, Accepted 24 Sep 1996, Published online: 11 Jul 2009

References

  • Anaguchi H., Hiraoka O., Yamasaki K., Naito S., Ota Y. Ligand binding characteristics of the carboxyl-terminal domain of the cytokine receptor homologous region of the granulocyte colony-stimulating factor receptor. J. Biol. Chem 1995; 270: 27845–27851
  • Bebbington C. R., Hentschel C. C. G. The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells. DNA cloning: A Practical Approach, D. M. Glover. IRL Press, Oxford 1985; 163–188
  • Brodsky F. M., Parham P., Bodmer W. F. Monoclonal antibodies to HLA-DRw determinants. Tissue Antigens 1980; 16: 30–48
  • Calvo J. C., Radicella J. P., Charreau E. H. Measurement of specific radioactivities in labelled hormones by self-displacement analysis. Biochem. J 1983; 212: 259–264
  • Chatta G. S., Price T. H., Allen R. C., Dale D. C. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994; 84: 2923–2929
  • Cunningham B. C., Jhurani P., Ng P., Wells J. A. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 1989; 243: 1330–1336
  • Cunningham B. C., Wells J. A. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 1989; 244: 1081–1085
  • de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992; 255: 306–312
  • Demetri G. D., Griffin J. D. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791–2808
  • Duhrsen U., Villeval J.-L., Boyd J., Kannourakis G., Morstyn G., Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074–2081
  • Elbein A. D. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Ann. Rev. Biochem 1987; 56: 497–534
  • Fukunaga R., Ishizaka-Ikeda E., Nagata S. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J. Biol. Chem 1990a; 265: 14008–14015
  • Fukunaga R., Ishizaka-Ikeda E., Seto Y., Nagata S. Expression cloning of a receptor for murine granulocyte colony-stimulating factor. Cell 1990b; 61: 341–350
  • Fukunaga R., Seto Y., Mizushima S., Nagata S. Three diiferent mRNAs encoding human granulocyte colony-stimulating factor receptor. Pmc. Natl Acad. Sci. USA 1990c; 87: 8702–8706
  • Fukunaga R., Ishizaka-Ikeda E., Pan C.-X., Seto Y., Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 1991; 10: 2855–2865
  • Garotta G., Ozmen L., Fountoulakis M., Dembic Z., van Loon A. P. G.M., Stuber D. Human interferon-g receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins. J Biol. Chem 1990; 265: 6908–6915
  • Hanazono Y., Hosoi T., Kuwaki T., Matsuki S., Miyazono K., Miyagawa K., Takaku F. Structural analysis of the receptors for granulocyte colony-stimulating factor on neutrophils. Exp. Hematol 1990; 18: 1097–1103
  • Hiraoka O., Anaguchi H., Ota Y. Evidence for the ligand-induced conversion from a dimer to a tetramer of the granulocyte colony-stimulating factor receptor. FEBS Letters 1994a; 356: 255–260
  • Hartley S. B., Crosbie J., Brink R., Kantor A. B., Basten A., Goodnow C. C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991; 353: 765–769
  • Hiraoka O., Anaguchi H., Yamasaki K., Fukunaga R., Nagata S., Ota Y. Ligand binding domain of granulocyte colony-stimulating factor receptor. J. Biol. Chem 1994b; 269: 22412–22419
  • Hiraoka O., Anaguchi H., Asakura A., Ota Y. Requirement for the immunoglobulin-like domain of granulocyte colony-stimulating factor receptor in formation of a 2:1 receptor-ligand complex. J. Biol. Chem 1995; 270: 25928–25934
  • Horan T., Wen J., Narhi L., Parker V., Garcia A., Arakawa T., Philo J. Dimerization of the extracellular domain of granulocyte-colony stimulating factor receptor by ligand binding: A monovalent ligand induces 2:2 complexes. Biochem 1996; 35: 4886–4896
  • Hulme E. C., Birdsall N. J. M. Strategy and tactics in receptor-binding studies. Receptor-ligand interactions: A practical approach, E. C. Hulme. IRL Press, New York 1992; 63–176
  • Ishizaka-Ikeda E., Fukunaga R., Wood W. I., Goeddel D. V., Nagata S. Signal transduction mediated by growth hormone receptor and its chimeric molecules with the granulocyte colony-stimulating factor receptor. Proc. Natl Acad. Sci. U.S.A 1993; 90: 123–127
  • Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. U.S.A 1985; 82: 488–492
  • Larsen A., Davis T., Curtis B. M., Gimpel S., Sims J. E., Cosman D., Park L., Sorenson E., March C. J., Smith C. A. Expression cloning of a human granulocyte colony-stimulating factor receptor: A structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J. Exp. Med 1990; 172: 1559–1570
  • Layton J. E., Morstyn G., Fabri L. J., Reid G. E., Burgess A. W., Simpson R. J., Nice E. C. Identification of a functional domain of human granulocyte colony-stimulating factor using neutralizing monoclonal antibodies. J. Biol. Chem 1991; 266: 23815–23823
  • Li J., Sartorelli A. C. Evidence for the glycosylation of the granulocyte colony-stimulating factor receptor. Biochem. Biophys. Res. Comm 1994; 205: 238–244
  • Lieschke G. J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K. J., Basu S., Zhan Y. F., Dunn A. R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994; 84: 1737–1746
  • Mizushima S., Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 1990; 18: 5322
  • Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–672
  • Munson P. J., Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry 1980; 107: 220–239
  • Nicholson S. E., Oates A. C, Harpur A. G., Ziemiecki A., Wilks A. F., Layton J. E. Tyrosine kinase JAKl is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine phosphorylated after receptor activation. Proc. Natl Acad. Sci. U.S.A 1994; 91: 2985–2988
  • Nicholson S. E., Novak U., Ziegler S. F., Layton J. E. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood 1995; 86: 3698–3704
  • Nicola N. Granulocyte colony-stimulating factor. Colony stimulating factors: Molecular and Cellular Biology, T. M. Dexter, J. M. Garland, N. G. Testa. Marcel Decker Inc., New York and Basel 1990; 77–109
  • Nicola N. A. Hemopoietic growth factors and their interactions with specific receptors. J. Cellular Physiology 1987; 5: 9–14, supplement
  • Palacios R., Steinmetz M. IL-3–dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in viva. Cell 1985; 41: 727–734
  • Prigent S. A., Stanley K. K., Siddle K. Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies. J. Biol. Chem. 1990; 265: 9970–9977
  • Tybulewicz V. L. J., Crawford C. E., Jackson P. K., Bronson R. T., Mulligan R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell B 1991; 1153–1157
  • Wijdenes J., Heinrich P. C., Muller-Newen G., Roche C., Gu Z.-J., Clemant C., Klein B. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gpl30 monoclonal antibodies. Eur. J. Immunol 1995; 25: 3474–3481

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.